2025 Safety and Availability Communications
This webpage was developed to provide the public with important information about the safety and availability of biological products.
January 2025
- FDA Requires Guillain-Barré Syndrome (GBS) Warning in the Prescribing Information for RSV Vaccines Abrysvo and Arexvy
January 7, 2025